Last reviewed · How we verify
Zentopharm GmbH — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
1 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Infectious Diseases · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Achaogen, Inc. · 1 shared drug class
- Assistance Publique - Hôpitaux de Paris · 1 shared drug class
- Bausch Health Americas, Inc. · 1 shared drug class
- BioVersys AG · 1 shared drug class
- Bosnalijek D.D · 1 shared drug class
- Capital Medical University · 1 shared drug class
- Dr. Reddy's Laboratories Limited · 1 shared drug class
- Incheon St.Mary's Hospital · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Zentopharm GmbH:
- Zentopharm GmbH pipeline updates — RSS
- Zentopharm GmbH pipeline updates — Atom
- Zentopharm GmbH pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Zentopharm GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/zentopharm-gmbh. Accessed 2026-05-16.